Pearls and pitfalls in the diagnosis and management of mitral annular calcification

Sebastiaan Dhont1,2,3, Gitte P H van den Acker3, Timothy W Churchill4

  • 1Department of Cardiology, Ziekenhuis Oost-Limburg, Genk, Belgium.

PubMed

Insights

Mitral annular calcification (MAC) is a growing cause of mitral stenosis, impacting heart function and increasing cardiovascular risk. Early diagnosis and management are key, prioritizing medical therapy and specialized interventions for severe cases.

Area of Science:

  • Cardiology
  • Valvular Heart Disease
  • Biomedical Engineering

Background:

  • Mitral annular calcification (MAC) is a progressive degenerative condition with significant clinical implications.
  • MAC is now the leading cause of mitral stenosis in developed nations, surpassing rheumatic heart disease.
  • It contributes to mitral valve dysfunction, arrhythmias, systemic embolization, and increased cardiovascular risk.

Purpose of the Study:

  • To review the clinical impact, pathophysiology, diagnosis, and management of MAC.
  • To highlight the challenges in diagnosing MAC-related valve dysfunction and the importance of multimodality imaging.
  • To discuss current management strategies and potential future therapeutic advances.

Main Methods:

  • Literature review of studies on MAC, focusing on pathophysiology, diagnosis, and management.
  • Analysis of diagnostic challenges and the role of advanced imaging techniques like 3D echocardiography and cardiac CT.
  • Evaluation of current treatment approaches, including medical therapy and interventional procedures.

Main Results:

  • MAC pathophysiology involves mechanical stress, inflammation, and osteogenic differentiation, accelerated by age, CKD, and metabolic issues.
  • Traditional echocardiography is often unreliable for diagnosing MAC-related dysfunction; multimodality imaging is crucial.
  • Symptoms may stem from combined valvular and myocardial disease, requiring careful hemodynamic assessment.

Conclusions:

  • Management of MAC should prioritize medical therapy for symptoms and comorbidities like HFpEF.
  • Interventional approaches (surgical, transcatheter) are high-risk and reserved for selected patients in specialized centers.
  • Future research may focus on therapies targeting calcification pathways and tailored devices.

Related Concept Videos

Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
458
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
312
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
253
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
294
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
251
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
306